Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDPK67b in preoperative untreated prostate cancer
NCT05580107Phase 1Recruiting
- Sponsor
- Med Discovery SA
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of MDPK67b in prostate cancer (PCa), sponsored by Med Discovery SA. Primary endpoint: Tolerability and Safety. Started Aug 2021; status: recruiting.
02
Drugs
MDPK67b
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05580107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580107.